Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.86 USD | +1.87% | +7.87% | -29.18% |
05-24 | HC Wainwright Adjusts Legend Biotech Price Target to $73 From $86, Maintains Buy Rating | MT |
05-24 | Deutsche Bank Starts Legend Biotech With Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.18% | 7.67B | |
+8.22% | 114B | |
+9.68% | 104B | |
-1.83% | 22.57B | |
-10.94% | 22.5B | |
-10.39% | 17.95B | |
-41.90% | 16.48B | |
-13.88% | 15.82B | |
+3.56% | 13.55B | |
+28.55% | 10.99B |
- Stock Market
- Equities
- LEGN Stock
- News Legend Biotech Corporation
- Legend Biotech's Loss Narrows in Q1 as Revenue Surges